Cover Image
市場調查報告書

多工診斷市場:全球產業分析·規模·市場佔有率·成長與趨勢與預測

Multiplexed Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

出版商 Transparency Market Research 商品編碼 297661
出版日期 內容資訊 英文 102 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
多工診斷市場:全球產業分析·規模·市場佔有率·成長與趨勢與預測 Multiplexed Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
出版日期: 2014年03月12日 內容資訊: 英文 102 Pages
簡介

本報告提供全球多工診斷技術(超高密度·高密度·中密度·低密度多工診斷及次世代定序)市場現況與展望調查分析,提供技術·應用·各地區的市場分析,市場促進成長要素,阻礙成長要素,及機會分析,彙整波特的五力分析,及主要企業簡介等,為您概述為以下內容。

第1章 簡介

第2章 摘要整理

第3章 多工診斷市場概要

  • 概要
  • 促進要素
  • 阻礙要素
  • 機會
  • 波特的五力分析

第4章 全球多工診斷市場:各技術

  • 概要
  • 比較分析
  • 超高密度多工診斷
    • 市場收益
    • oligo核苷酸陣列
    • 噬菌體展示
  • 高密度多工診斷
    • 市場收益
    • 細菌人工染色體陣列
    • 蛋白質陣列
  • 中密度多工診斷
    • 市場收益
    • 微珠陣列
    • 抗體陣列
    • 反轉陣列
    • 質譜分析
  • 低密度多工診斷
    • 市場收益
    • Quantitative PCR Bead-based
    • 微孔盤化驗
  • 次世代定序化驗

第5章 全球多工診斷市場:各應用領域

  • 概要
  • 感染疾病診斷
  • 癌症
  • 自體免疫疾病
  • 心臟疾病
  • 過敏
  • 其他

第6章 全球多工診斷市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區

第7章 建議

  • 成功的市場策略

第8章 企業簡介

  • Affymetrix, Inc.
    • 企業概要
    • 財務概要
    • 產品系列
    • 商務策略
    • 近幾年的發展
  • Agilent Technologies, Inc.
  • bioMerieux, Inc.
  • Bio-Rad Laboratories, Inc.
  • F. Hoffman-La Roche, Ltd.
  • Gen-Probe, Inc.
  • Life Technologies Corporation
  • Luminex Corporation
  • Seegene, Inc.

圖表清單

目錄

This report covers the market analysis of the multiplexed diagnostics technologies namely, very high, high, medium, low density multiplexed assays & next-generation sequencing. This report contains qualitative information about oligonucleotide arrays, phage display, bacterial artificial chromosome arrays, protein arrays, bead-based arrays, antibody arrays, reverse arrays, mass spectrometry, quantitative PCR bead-based and microplate assays and next-generation sequencing. Further this market is also segmented on the basis of several application areas of multiplexed diagnostics, namely, infectious disease diagnosis, oncology, autoimmune diseases, cardiac conditions, allergies and others (Alzheimer's disease, diabetes, kidney toxicity and HIV). The global multiplexed diagnostics market has phenomenally increased the volume and quality of diagnostic procedures by reducing the turnaround time and analyzing multiple analytes in a single cycle and thereby resulting in rapid adoption of such techniques. The stake holders in this market include market players who provide multiplexed diagnostic assay kits, reagents, solutions and systems.

The qualitative details of the market dynamics of the multiplexed diagnostics market such as drivers, restraints and opportunities that influence the current nature and future status of this field are covered under the market overview section of this report. Impact factors such as market attractiveness analysis and Porter's five forces analysis have also been provided in the market overview section of the report in order to give a thorough analysis of the overall competitive scenario in the global multiplexed diagnostics market. The market size and forecast in terms of USD million has been provided in the report for the period 2011 to 2019. This report also includes the overall market growth rate (Compounded Annual Growth Rate) of technologies, applications and geographic market for the period 2013 to 2019, considering 2012 as the base year.

Geographically, the global multiplexed diagnostics market has been categorized into four geographical regions, namely North America, Europe, Asia-Pacific and Rest of the World (RoW). This section further includes the market size and forecast of the mentioned regional markets for the period 2011 to 2019 along with their growth rates. This report also includes strategic recommendations, which would be useful for the current and future market players to sustain and grow their share in the global multiplexed diagnostics market. This report concludes with the company profiles section which comprises key information about the major players in this market. Some of the key players profiled in this report include Affymetrix, Agilent Technologies, Gen-Probe, Inc., bioMerieux, Life Technologies, Luminex Corporation and Illumina, Inc.

The global multiplexed diagnostics market is segmented as follows:

Multiplexed Diagnostics Market, by Technology

  • Very high density multiplexed assays
    • Oligonucleotide Arrays
    • Phage Display
  • High Density Multiplexed Assays
    • Bacterial Artificial Chromosome Arrays
    • Protein Arrays
  • Medium Density Multiplexed Assays
    • Bead-based Arrays
    • Antibody Arrays
    • Reverse Arrays
    • Mass Spectroscopy
  • Low Density Multiplexed Arrays
    • Quantitative PCR Bead-based Assays
    • Microplate Assays
  • Next-Generation Sequencing

Multiplexed Diagnostics Market, by Application

  • Infectious Disease Diagnosis
  • Oncology
  • Autoimmune diseases
  • Cardiac
  • Allergies
  • Others

Multiplexed Diagnostics Market, by Geography

  • Overview
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Table of Contents

Chapter 1 Introduction

  • 1.1 Report Description
  • 1.2 Research Methodology
  • 1.3 Market Segmentation: Multiplexed Diagnostics Market
  • 1.4 List of Abbreviations

Chapter 2 Executive Summary

Chapter 3 Multiplexed Diagnostics Market Overview

  • 3.1 Overview - Current Market Scenario and Future Market Trends
    • 3.1.1 Global Multiplexed Assay Market Revenue, 2011 - 2019 (USD Million)
  • 3.2 Drivers
    • 3.2.1 Completion of the Human Genome Project
    • 3.2.2 Increasing Prevalence of Cancer and Infectious Diseases
    • 3.2.3 Multiple Usage
    • 3.2.4 Evolving Regulatory landscape
  • 3.3 Restraints
    • 3.3.1 Costly Equipment
    • 3.3.2 Lack of skilled labour
    • 3.3.3 Lack of Reimbursement Coverage
  • 3.4 Opportunities
    • 3.4.1 Automation of the Multiplexed Diagnostic Instrument
    • 3.4.2 Development Of Generic Platforms
  • 3.5 Porter's Five Force Analysis for the Global Multiplexed Diagnostics Market
    • 3.5.1 Bargaining Power of Suppliers
    • 3.5.2 Bargaining Power of Buyers
    • 3.5.3 Threat of New Entrants
    • 3.5.4 Threat of Substitutes
    • 3.5.5 Competitive Rivalry
    • 3.6 Market Attractiveness Analysis of Multiplexed Assay Market, by Geography

Chapter 4 Global Multiplex Assays Market, by Technology

  • 4.1 Overview - Current Market Scenario and Future Market Trends
  • 4.2 Comparative Analysis: Global Multiplexed Diagnostics Market, by Technology, 2012 & 2019 (Value %)
  • 4.3 Very High Density Multiplexed Assays (> 10,000-plex)
    • 4.3.1 Global Very High Density Multiplexed Assays Market Revenue, 2011 - 2019, (USD Million)
    • 4.3.2 Oligonucleotide Arrays
    • 4.3.3 Phage Display
  • 4.4 High Density Multiplexed Assays (500 ≤ plex ≤ 10,000)
    • 4.4.1 Global High Density Multiplexed Assays Market Revenue, 2011 - 2019, (USD Million)
    • 4.4.2 Bacterial Artificial Chromosome Arrays
    • 4.4.3 Protein Arrays
  • 4.5 Medium Density Multiplexed Assays (plex < 500)
    • 4.5.1 Global Medium Density Multiplexed Assays Market Revenue, 2011 - 2019 (USD Million)
    • 4.5.2 Bead-based Arrays
    • 4.5.3 Antibody Arrays
    • 4.5.4 Reverse Arrays
    • 4.5.5 Mass Spectrometry
  • 4.6 Low Density Multiplexed Assays (plex ≤ 5)
    • 4.6.1 Global Low Density Multiplexed Assays Market Revenue, 2011 - 2019, (USD Million)
    • 4.6.2 Quantitative PCR Bead-based
    • 4.6.3 Microplate Assays
  • 4.7 Next-Generation Sequencing Assays
    • 4.7.1 Global Next Generation Sequencing Market Revenue, 2011 - 2019, (USD Million)

Chapter 5 Global Multiplex Diagnostics Market, By Application

  • 5.1 Overview - Current Market Scenario and Future Market Trends
    • 5.1.1 Comparative Analysis: Global Multiplexed Diagnostics Market, by Application, 2012 & 2019 (Value %)
  • 5.2 Infectious Disease Diagnosis
    • 5.2.1 Global Multiplexed Infectious Disease Diagnostics Market Revenue, 2011 - 2019, (USD Million)
  • 5.3 Oncology
    • 5.3.1 Global Multiplexed Oncology Diagnostics Market Revenue, 2011 - 2019, (USD Million)
  • 5.4 Autoimmune diseases
    • 5.4.1 Global Multiplexed Autoimmune Disease Diagnostics Market Revenue, 2011 - 2019, (USD Million)
  • 5.5 Cardiac
    • 5.5.1 Global Multiplexed Cardiac Diagnostics Market Revenue, 2011 - 2019, (USD Million)
  • 5.6 Allergies
    • 5.6.1 Global Multiplexed Allergy Diagnostics Market Revenue, 2011 - 2019, (USD Million)
  • 5.7 Others
    • 5.7.1 Global Other Multiplexed Diagnostic Applications Market Revenue, 2011 - 2019, (USD Million)

Chapter 6 Global Multiplexed Diagnostics Market, by Geography

  • 6.1 Introduction
    • 6.1.1 Comparative Analysis: Global Multiplexed Diagnostics Market, by Geography (Value %)
  • 6.2 North America
    • 6.2.1 North America Multiplexed Diagnostics Market Revenue, 2011 - 2019 (USD Million)
  • 6.3 Europe
    • 6.3.1 Europe Multiplexed Diagnostics Market Revenue, 2011 - 2019 (USD Million)
  • 6.4 Asia-Pacific
    • 6.4.1 Asia-Pacific Multiplexed Diagnostics Market Revenue, 2011 - 2019 (USD Million)
  • 6.5 Rest of the World (RoW)
    • 6.5.1 Rest of the World (RoW) Multiplexed Diagnostics Market Revenue, 2011 - 2019 (USD Million)

Chapter 7 Recommendations

  • 7.1 Market Strategies for Success
    • 7.1.1 Innovation in Technology
    • 7.1.2 Investing in Emerging Economies

Chapter 8 Company Profiles

  • 8.1 Affymetrix, Inc.
    • 8.1.1 Company Overview
    • 8.1.2 Financial Overview
    • 8.1.3 Product Portfolio
    • 8.1.4 Business Strategies
    • 8.1.4.1 Diversified Product Portfolio
    • 8.1.4.2 Partnerships
    • 8.1.5 Recent Developments
  • 8.2 Agilent Technologies, Inc.
    • 8.2.1 Company Overview
    • 8.2.2 Financial Overview
    • 8.2.3 Product Portfolio
    • 8.2.4 Business Strategies
    • 8.2.4.1 Acquisitions
    • 8.2.4.2 Expansion into Emerging Markets
    • 8.2.5 Recent Developments
  • 8.3 bioMerieux, Inc.
    • 8.3.1 Company Overview
    • 8.3.2 Financial Overview
    • 8.3.3 Product Portfolio
    • 8.3.4 Business Strategies
    • 8.3.4.1 Acquisitions
    • 8.3.4.2 Expansion
    • 8.3.4.3 Partnerships and Collaborations
    • 8.3.5 Recent Developments
  • 8.4 Bio-Rad Laboratories, Inc.
    • 8.4.1 Company Overview
    • 8.4.2 Financial Overview
    • 8.4.3 Product Portfolio
    • 8.4.4 Business Strategies
    • 8.4.4.1 Mergers and Acquisitions
    • 8.4.4.2 Partnership
    • 8.4.5 Recent Developments
      • 8.5 Illumina, Inc.
    • 8.5.1 Company Overview
    • 8.5.2 Financial Overview
    • 8.5.3 Product Portfolio
    • 8.5.4 Business Strategies
    • 8.5.4.1 Strategic Acquisitions
    • 8.5.4.2 Expansion
    • 8.5.4.3 Partnership
    • 8.5.5 Recent Developments
  • 8.6 F. Hoffman-La Roche, Ltd.
    • 8.6.1 Company Overview
    • 8.6.2 Financial Overview
    • 8.6.3 Product Portfolio
    • 8.6.4 Business Strategies
    • 8.6.5 Recent Developments
  • 8.7 Gen-Probe, Inc.
    • 8.7.1 Company Overview
    • 8.7.2 Financial Overview
    • 8.7.3 Product Portfolio
    • 8.7.4 Business Strategies
    • 8.7.4.1 Expansion
    • 8.7.5 Recent Developments
  • 8.8 Life Technologies Corporation
    • 8.8.1 Company Overview
    • 8.8.2 Financial Overview
    • 8.8.3 Business Strategies
    • 8.8.3.1 Partnerships and Collaborations
    • 8.8.4 Recent Developments
  • 8.9 Luminex Corporation
    • 8.9.1 Company Overview
    • 8.9.2 Financial Overview
    • 8.9.3 Product Portfolio
    • 8.9.4 Business Strategies
    • 8.9.4.1 Diversified Product Portfolio
    • 8.9.4.2 Partnerships
    • 8.9.5 Recent Developments
  • 8.10 Seegene, Inc.
    • 8.10.1 Company Overview
    • 8.10.2 Financial Overview
    • 8.10.3 Product Portfolio
    • 8.10.4 Business Strategies
    • 8.10.5 Recent Developments

List of Figures

  • FIG. 1 Multiplexed Diagnostics Market Segmentation
  • FIG. 2 Global Multiplexed Diagnostics Market Revenue, by Technology, 2012 (USD Million)
  • FIG. 3 Global Multiplexed Diagnostics Market Revenue, by Geography, 2012 (USD Million)
  • FIG. 4 Global Multiplexed Diagnostics Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 5 Porter's Five Force Analysis: Global Multiplexed Diagnostics Market
  • FIG. 6 Market Attractiveness Analysis of Global Multiplexed Diagnostics Market, by Geography
  • FIG. 7 Comparative Analysis: Global Multiplexed Diagnostics Market, by Technology, 2012 & 2019 (Value %)
  • FIG. 8 Global Very High Density Multiplexed Assays Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 9 Global High Density Multiplexed Assays Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 10 Global Medium Density Multiplexed Assays Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 11 Global Low Density Multiplexed Assays Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 12 Global Next Generation Sequencing Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 13 Comparative Analysis: Global Multiplexed Diagnostics Market, by Application, 2012 & 2019 (Value %)
  • FIG. 14 Global Multiplexed Infectious Disease Diagnostics Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 15 Global Multiplexed Oncology Diagnostics Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 16 Global Multiplexed Autoimmune Disease Diagnostics Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 17 Global Multiplexed Cardiac Diagnostics Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 18 Global Multiplexed Allergy Diagnostics Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 19 Global Other Multiplexed Diagnostic Applications Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 20 Comparative Analysis: Global Multiplexed Diagnostics Market, by Geography (Value %)
  • FIG. 21 North America Multiplexed Diagnostics Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 22 Europe Multiplexed Diagnostics Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 23 Asia-Pacific Multiplexed Diagnostics Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 24 Rest of the World (RoW) Multiplexed Diagnostics Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 25 Affymetrix, Inc.: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 26 Agilent Technologies, Inc.: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 27 bioMerieux, Inc.: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 28 Bio-Rad Laboratories, Inc.: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 29 Illumina, Inc.: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 30 F. Hoffman-La Roche, Ltd.: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 31 Gen-Probe, Inc.: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 32 Life Technologies Corporation, Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 33 Luminex Corporation: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 34 Seegene, Inc.: Annual Revenue, 2010 - 2012 (USD Million)

List of Tables

  • TABLE 1 List of Abbreviations
  • TABLE 2 Market Snapshot: Global Multiplexed Diagnostics Market
  • TABLE 3 Global Multiplexed Diagnostics Market Revenue, by Technology 2011 - 2019 (USD Million)
  • TABLE 4 Global Multiplexed Diagnostics Market Revenue, by Application, 2011 - 2019 (USD Million)
  • TABLE 5 Global Multiplexed Diagnostics Market Revenue, by Geography, 2011 - 2019 (USD Million)
Back to Top